These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38424650)

  • 1. Eye signs as a novel risk predictor in pulmonary arterial hypertension associated with systemic lupus erythematosus.
    Li J; Xiong J; Liu P; Peng Y; Cai S; Fang X; Yu S; Zhao J; Wu R
    Adv Rheumatol; 2024 Feb; 64(1):15. PubMed ID: 38424650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Conjunctival Microvasculation Combined with Echocardiography in Evaluating Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus.
    Xiong J; Yu S; Liu R; Fang X; Wu R
    Dis Markers; 2021; 2021():2135942. PubMed ID: 34868390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total iron binding capacity: an independent predictor of prognosis for pulmonary arterial hypertension in systemic lupus erythematosus.
    Xiong J; Peng Y; Li J; Cai S; Wu R
    Scand J Rheumatol; 2024 Jan; 53(1):44-48. PubMed ID: 37605880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of heart rate recovery in female patients with pulmonary arterial hypertension due to systemic lupus erythematosus.
    Yang GL; Guo J; Pudasaini B; Yuan P; Gong SG; Wang L; Zhao QH; Yang WL; Jiang R; Zhou C; Liu JM
    Clin Respir J; 2019 Sep; 13(9):545-554. PubMed ID: 31295761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients.
    Lan WF; Deng Y; Dai P; Wu DD; Hu J; Liao J; Meng H
    Lupus; 2024 Feb; 33(2):155-165. PubMed ID: 38182135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and prognostic factors of systemic lupus erythematosus-associated pulmonary arterial hypertension: A PRISMA-compliant systematic review and meta-analysis.
    Qian J; Wang Y; Huang C; Yang X; Zhao J; Wang Q; Tian Z; Li M; Zeng X
    Autoimmun Rev; 2016 Mar; 15(3):250-7. PubMed ID: 26640159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review.
    Li M; Tian Z; Qian J; Huang C; Zhao J; Wang Q; Song Y; Tian X; Li M; Liu J; Zeng X
    Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35256456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines.
    Li Y; Qian J; Dong X; Zhao J; Wang Q; Wang Y; Zeng X; Tian Z; Li M
    Arthritis Res Ther; 2024 May; 26(1):109. PubMed ID: 38802957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension.
    Wronski SL; Mordin M; Kelley K; Anguiano RH; Classi P; Shen E; Manaker S
    Lung; 2020 Feb; 198(1):65-86. PubMed ID: 31722043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis.
    Hoeper MM; Pausch C; Olsson KM; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Ewert R; Kaemmerer H; Kabitz HJ; Skowasch D; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Eisenmann S; Schmidt KH; Rosenkranz S; Lange TJ
    J Heart Lung Transplant; 2022 Jul; 41(7):971-981. PubMed ID: 35430147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
    Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic and prognostic value of growth differentiation factor-15 in systemic lupus erythematosus-associated pulmonary arterial hypertension.
    Qian J; Ding Y; Yang X; Wang Q; Zhao J; Liu Y; Tian Z; Wang Y; Li M; Zeng X
    Pulm Circ; 2023 Jan; 13(1):e12195. PubMed ID: 36788942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up.
    Xanthouli P; Koegler M; Marra AM; Benjamin N; Fischer L; Eichstaedt CA; Harutyunova S; Nagel C; Grünig E; Egenlauf B
    Respir Res; 2020 May; 21(1):127. PubMed ID: 32448256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study.
    Deng X; Jin B; Li S; Li Y; Zhou H; Wu Y; Yan M; Hu Y; Qiu Q; Zhang G; Zheng X
    Clin Respir J; 2019 Nov; 13(11):693-699. PubMed ID: 31419027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of non-invasive right ventricle to pulmonary circulation coupling in systemic lupus erythematosus patients with pulmonary arterial hypertension.
    Guo X; Lai J; Wang H; Tian Z; Wang Q; Zhao J; Li M; Fang Q; Fang L; Liu Y; Zeng X
    Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):111-118. PubMed ID: 31872222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial Measurements of N-Terminal Pro-B-Type Natriuretic Peptide Serum Level for Monitoring Pulmonary Arterial Hypertension in Children.
    Said F; Haarman MG; Roofthooft MTR; Hillege HL; Ploegstra MJ; Berger RMF
    J Pediatr; 2020 May; 220():139-145. PubMed ID: 32113658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right ventricular dyssynchrony for the prediction of prognosis in patients with systemic lupus erythematosus-aaociated pulmonary arterial hypertension: a study with two-dimensional speckle tracking.
    Tan XL; Deng Y; Lan WF; Dai P; Hu J; Lan J
    Int J Cardiovasc Imaging; 2024 May; 40(5):967-979. PubMed ID: 38461202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension.
    Haddad F; Contrepois K; Amsallem M; Denault AY; Bernardo RJ; Jha A; Taylor S; Arthur Ataam J; Mercier O; Kuznetsova T; Vonk Noordegraaf A; Zamanian RT; Sweatt AJ
    Chest; 2022 May; 161(5):1347-1359. PubMed ID: 34774527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
    Qu J; Li M; Zhang X; Zhang M; Zuo X; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Qian J; Huang C; Zhao J; Wang Q; Liu Y; Tian Z; Wang Y; Wei W; Zeng X
    Respir Res; 2023 Sep; 24(1):220. PubMed ID: 37689662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use of macitentan in the treatment of connective tissue disease-associated pulmonary arterial hypertension.
    Song X; Sheng X; Ding L; Wu J; Chang X; Zhou E; Cao J; Cheng T; Wang M
    J Thorac Dis; 2024 Mar; 16(3):2060-2069. PubMed ID: 38617769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.